Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Fortpied, C.
64  Ergebnisse:
Personensuche X
?
1

MO-0717 Seasonality of radiotherapy efficacy for head & nec..:

Blanchard, P. ; Lacas, B. ; Bourhis, J....
Radiotherapy and Oncology.  182 (2023)  - p. S587-S588 , 2023
Link: https://doi.org/10.1016/..
 
?
2

OC-0764 The rate and spatial location of local recurrences:..:

Kaidar-Person, O. ; Giasafaki, P. ; Boersma, L....
Radiotherapy and Oncology.  182 (2023)  - p. S629-S631 , 2023
Link: https://doi.org/10.1016/..
 
?
3

OC-0611 Lungtech EORTC 22113-08113 prospective multicenter ..:

Adebahr, S. ; Nestle, U. ; Hurkmans, C....
Radiotherapy and Oncology.  182 (2023)  - p. S495-S497 , 2023
Link: https://doi.org/10.1016/..
 
?
4

EARLY FDG‐PET ADAPTED TREATMENT OF LIMITED STAGE HODGKIN LY..:

Federico, M. ; Fortpied, C. ; Stepanishyna, Y....
Hematological Oncology.  41 (2023)  S2 - p. 159-160 , 2023
Link: https://doi.org/10.1002/..
 
?
5

OC-0269 Early toxicity of SBRT for oligometastatic cancer p..:

Alongi, F. ; Ricardi, U. ; Scorsetti, M....
Radiotherapy and Oncology.  182 (2023)  - p. S205 , 2023
Link: https://doi.org/10.1016/..
 
?
6

OC-0934 Outcomes of the EORTC 22922/10925 randomised trial ..:

Kaidar-Person, O. ; Fortpied, C. ; Hol, S....
Radiotherapy and Oncology.  170 (2022)  - p. S824-S825 , 2022
Link: https://doi.org/10.1016/..
 
?
7

OC-0599 Factors associated with SBRT doses in oligometastat..:

Guckenberger, M. ; Alongi, F. ; Ricardi, U....
Radiotherapy and Oncology.  170 (2022)  - p. S523-S524 , 2022
Link: https://doi.org/10.1016/..
 
?
8

SP-0520 Going beyond clinical trials in the era of real wor..:

Fortpied, C.
Radiotherapy and Oncology.  170 (2022)  - p. S461-S462 , 2022
Link: https://doi.org/10.1016/..
 
?
9

PD-0740 Real-world patient & treatment characteristics of o..:

Guckenberger, M. ; Ricardi, U. ; Scorsetti, M....
Radiotherapy and Oncology.  161 (2021)  - p. S568-S569 , 2021
Link: https://doi.org/10.1016/..
 
?
10

RELAPSES IN INTERIM PET NEGATIVE LIMITED STAGE HODGKIN LYMP..:

Aurer, I. ; Neven, A. ; Fiaccadori, V....
Hematological Oncology.  39 (2021)  S2 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
11

Independent external validation using the EORTC HNCG-ROG 12..:

Sharabiani, M. ; Clementel, E. ; Andratschke, N....
Radiotherapy and Oncology.  161 (2021)  - p. 35-39 , 2021
Link: https://doi.org/10.1016/..
 
?
12

BASELINE MAXIMUM TUMOUR DIAMETER IS ASSOCIATED WITH EVENT‐F..:

Phillips, E. H. ; Counsell, N. ; Illidge, T....
Hematological Oncology.  39 (2021)  S2 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
13

OC-0278 Accelerated CH-RT with/without nimorazole for p16- ..:

Grégoire, V. ; Tao, Y. ; Kaanders, J....
Radiotherapy and Oncology.  161 (2021)  - p. S187-S188 , 2021
Link: https://doi.org/10.1016/..
 
?
14

Quality assurance of radiotherapy in the ongoing EORTC 1420..:

Stelmes, J-J ; Vu, E. ; Grégoire, V....
Radiation Oncology.  16 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
15

PH-0288: Independent external validation of a logistic regr..:

Sharabiani, M. ; Clementel, E. ; Andratschke, N....
Radiotherapy and Oncology.  152 (2020)  - p. S147-S148 , 2020
Link: https://doi.org/10.1016/..
 
1-15